2 min read
RAPS US Convergence
Meet Veristat at RAPS US Convergence 2025
Where Regulatory Excellence Meets Real-World Impact
Veristat is delighted...
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.
Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.
Learning Points
- What are Drug Device Combination (DDC) products
- What is Article 117 of the MDR
- The impact of Article 117 on Manufacturers
Meet Veristat. Learn More.
Get the Latest News
Categories
- Regulatory Consulting (125)
- Regulatory Submissions (120)
- Clinical Trial Regulations (110)
- COVID-19 (46)
- Strategic Consulting (35)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Oncology (13)
- Success Stories (13)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Medical Writing (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Neurology/CNS (1)
- Rare Diseases (1)
5 min read
Clinical Outsourcing Group CRO Summit - Bay Area
Aug 28, 2025 Veristat Events